A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects
Clinical trial NCT04512872 · COMPLETED
Trial details
- NCT number
- NCT04512872
- Sponsor
- Celltrion
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-20
- Primary completion
- 2021-05-04
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.